Email
Print
Methadone Market Overview
Methadone Market size is estimated to reach $105.3 million by 2026, growing at a CAGR of 4% over 2021-2026. Methadone is a medication that is used to treat chronic pain and is a synthetic narcotic analgesic which is part of a category called opioids. Methadone have a class of drugs known as opioid analgesics which is indicated for the management of pain in patients. Methadone has some affinity for the NMDA ionotropic glutamate receptor and also acts by binding to the µ-opioid receptor where the agonism of the µ-opioid receptors is used for the treatment of pain.
Acute encephalopathy are detected in methadone intoxicated patients where brain MRI is helpful for the detection of methadone-induced encephalopathy. Growing prevalence of chronic diseases among people and rising incidence in opioid misuse are the major factors driving the growth of this market. Furthermore, increasing research and development activities regarding drugs is set to further enhance the overall market demand for Methadone Market for the period 2021-2026.
Report Coverage
The report: “Methadone Market Forecast (2021-2026)”, by IndustryARC, covers an in-depth analysis of the following segments of the Methadone Market.
By Route of Administration: Oral, and Injectable
By Therapeutic Area: Pain Treatment, Detoxification, and Maintenance Therapy
By End-Use Industry: Hospitals, Pharmacies, and Others
By Geography: North America (U.S., Canada, Mexico), Europe (U.K, Germany, Italy, France, Spain, Russia, Rest of Europe), Asia Pacific (China, Australia, Japan, South Korea, India, Rest of Asia Pacific), South America (Brazil, Argentina, Others) and Rest of the World (Middle East, Africa)
Key Takeaways
- Geographically, in 2020, North America dominated the Methadone Market owing to growing incidence of drug addiction and higher adoption rate of opioid analgesics.
- Growing prevalence of chronic disease and rising incidence in opioid misuse are likely to aid in the market growth of the Methadone.
- Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Methadone Market report.
- Increasing side effects is set to create hurdles for the Methadone Market.
Methadone Market Size, By Therapeutic Area 2020-2026 (USD Million)
For more details on this report - Request for Sample
Methadone Segment Analysis – By Route of Administration
The global Methadone Market based on Route of Administration can be further segmented into Oral, and Injectable. The Oral segment is the major segment generating revenue in 2020. This is owing to the availability of drugs in in various forms and dosage. Moreover, it provides safety, ease of ingestion, pain avoidance and versatility to accommodate. The Injectable segment is estimated to register the fastest CAGR of 0.5% for the period 2021-2026. This is owing to the quick results and action in pain that increases the demand of injectable route of administration leading to the growth of this segment.
Methadone Segment Analysis – By Therapeutic Area
The global Methadone Market based on Therapeutic Area can be further segmented into, Pain Treatment, Detoxification, and Maintenance Therapy. The pain treatment segment registers for the Methadone highest market share in 2020. This is owing to methadone is an effective narcotic analgesic which is used in the treatment of patients with pain. Moreover, it is inexpensive and relatively safe that increases the demand of methadone in pain treatment and are rising the growth of this segment. The Detoxification segment is estimated to register the fastest CAGR of 1.5% over 2021-2026. This is mainly owing to methadone works as detoxification that improve energy, improve complexion and also reduce acute encephalopathy that increases the demand of methadone and are increasing the growth of this market.
Methadone Segment Analysis – By Geography
North America dominated the Methadone Market with major share of 40% in 2020. This is owing to growing incidence of drug addiction and higher adoption rate of opioid analgesics. According to United Nation Office on Drug and Crime (UNODC) in 2017, more than 47,000 people have deaths owing to opioid overdose that increases the demand of methadone which acts as opioid receptors and are rising the growth of this market. However, Asia Pacific is estimated to outpace all the regions by clocking the highest CAGR of 2% during the forecast period 2021-2026 owing to rising population and increasing development in healthcare.
Methadone Market Drivers
Growing Prevalence of Chronic Disease
Growing number of patients associated with therapeutic pain treatment and other chronic disease increases the growth of the Methadone Market. According to National Health Council, in 2020 about 157 million in U.S. have chronic disease that increasing the use of methadone as it provides ionotropic glutamate receptor and are increasing the growth of the Methadone Market over 2021-2026.
Rising Incidence in Opioid Misuse
Rising number of people addicted with various opioid such as heroin and morphine is driving the growth of this market. Moreover, increase in awareness towards the use of this medication which can be used for pain management also increases the growth of Methadone Market over 2021-2026.
Covid-19 Impact:
COVID-19 pandemic had greatly affected the Methadone Market. Owing to pandemic, there is lockdowns, shutdowns of clinics and many more where people are getting pediatric for their treatment in clinics owing to increasing risk of spreading virus that decreases the demand of methadone and are negatively affected the growth of this market.
Methadone Market Challenges
Increasing Side Effects
The factors that is set to impede the growth of the Methadone Market are increasing side effects such as constipation, nausea, vomiting etc. Moreover, stringent government approval is set to create hurdles for the Methadone Market.
Methadone Market Landscape
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Methadone Market. Methadone top 10 companies include, Diskets, Methadoes, Aurolife Pharma LLC., Macfarlan Smith, VistaPharm, Qinghai Pharm, CentralPharm, Mallinckrodt, AIMS, and Roxane.
Developments
- In October 2019, AIMS (All India Institute of Medical Science) has launched new mobile vans treatment for opioid addicted patients that helps to reduce opioid reduction. So, the Methadone drugs are provided to patients and are increasing the market growth.
Relevant Reports:
Report Code: HCR 0217
Report Code: HCR 99193
For more Lifesciences and Healthcare Market reports, please click here
1. Methadone Market Overview
1.1 Definitions and Scope
2. Methadone Market Executive Summary
2.1 Market Size and Key Trends
2.2 Key trends by Product
2.3 Key trends by End-Use Industry
2.4 Key trends by Geography
3. Methadone Market Landscape
3.1 Market Share Analysis- Key Companies
3.2 Product Benchmarking- Key Companies
3.3 Financial Analysis - Key Companies
3.4 Patent Analysis
3.5 Pricing Analysis
4. Methadone Market- Startup companies Scenario Premium Premium
4.1 Key startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Application Analysis
4.1.4 Venture Capital and Funding Scenario
5. Methadone Market- Industry Market Entry Scenario Premium Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case Studies of successful ventures
6. Methadone Market Forces
6.1 Market Drivers
6.2 Market Constraints/Challenges
6.3 Porters Five Force Model
6.3.1 Bargaining Power of Suppliers
6.3.2 Bargaining Powers of Customers
6.3.3 Threat of New Entrants
6.3.4 Rivalry Among Existing Players
6.3.5 Threat of Substitutes
7. Methadone Market Strategic Analysis
7.1 Value Chain Analysis
7.2 Opportunities Analysis
7.3 Market Life Cycle
8. Methadone Market– By Route of Administration (Market Size -$Million/$Billion)
8.1 Oral
8.2 Injectable
9. Methadone Market– By Therapeutic Area (Market Size -$Million/$Billion)
9.1 Pain Treatment
9.2 Detoxification
9.3 Maintenance Therapy
10. Methadone Market– By End-Use Industry (Market Size -$Million/$Billion)
10.1Hospitals
10.2Pharmacies
10.3Others
11. Methadone Market- By Geography (Market Size -$Million/$Billion)
11.1 North America
11.1.1 U.S.
11.1.2 Canada
11.1.3 Mexico
11.2 Europe
11.2.1 U.K.
11.2.2 Germany
11.2.3 Italy
11.2.4 France
11.2.5 Spain
11.2.6 Russia
11.2.7 Rest of Europe
11.3 Asia-Pacific
11.3.1 China
11.3.2 Australia
11.3.3 Japan
11.3.4 South Korea
11.3.5 India
11.3.6 Rest of Asia-Pacific
11.4 South America
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Others
11.5 Rest of the World
11.5.1 Middle East
11.5.2 Africa
12. Methadone Market Entropy
13. Methadone Market- Industry / Segment Competition landscape Premium Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Key companies
13.1.2 Market Share by Region- Key companies
13.1.3 Market Share at Global Level- Key companies
13.1.4 Best Practices for Companies
14. Methadone Market- Key Company List by Country Premium Premium
15. Methadone Market Company Analysis
15.1 Company Revenue, Products, M&A, Developments
15.2 Company 1
15.3 Company 2
15.4 Company 3
15.5 Company 4
15.6 Company 5
15.7 Company 6
15.8 Company 7
15.9 Company 8
15.10 Company 9
15.11 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
LIST OF TABLES
1.Global METHADONE MARKET, BY MODE OF ADMINISTRATION Market 2023-2030 ($M)1.1 ORAL MEDICINE Market 2023-2030 ($M) - Global Industry Research
1.1.1 Tablets Market 2023-2030 ($M)
1.1.2 Liquid Market 2023-2030 ($M)
1.2 INJECTIONS Market 2023-2030 ($M) - Global Industry Research
2.Global METHADONE MARKET, BY MODE OF ADMINISTRATION Market 2023-2030 (Volume/Units)
2.1 ORAL MEDICINE Market 2023-2030 (Volume/Units) - Global Industry Research
2.1.1 Tablets Market 2023-2030 (Volume/Units)
2.1.2 Liquid Market 2023-2030 (Volume/Units)
2.2 INJECTIONS Market 2023-2030 (Volume/Units) - Global Industry Research
3.North America METHADONE MARKET, BY MODE OF ADMINISTRATION Market 2023-2030 ($M)
3.1 ORAL MEDICINE Market 2023-2030 ($M) - Regional Industry Research
3.1.1 Tablets Market 2023-2030 ($M)
3.1.2 Liquid Market 2023-2030 ($M)
3.2 INJECTIONS Market 2023-2030 ($M) - Regional Industry Research
4.South America METHADONE MARKET, BY MODE OF ADMINISTRATION Market 2023-2030 ($M)
4.1 ORAL MEDICINE Market 2023-2030 ($M) - Regional Industry Research
4.1.1 Tablets Market 2023-2030 ($M)
4.1.2 Liquid Market 2023-2030 ($M)
4.2 INJECTIONS Market 2023-2030 ($M) - Regional Industry Research
5.Europe METHADONE MARKET, BY MODE OF ADMINISTRATION Market 2023-2030 ($M)
5.1 ORAL MEDICINE Market 2023-2030 ($M) - Regional Industry Research
5.1.1 Tablets Market 2023-2030 ($M)
5.1.2 Liquid Market 2023-2030 ($M)
5.2 INJECTIONS Market 2023-2030 ($M) - Regional Industry Research
6.APAC METHADONE MARKET, BY MODE OF ADMINISTRATION Market 2023-2030 ($M)
6.1 ORAL MEDICINE Market 2023-2030 ($M) - Regional Industry Research
6.1.1 Tablets Market 2023-2030 ($M)
6.1.2 Liquid Market 2023-2030 ($M)
6.2 INJECTIONS Market 2023-2030 ($M) - Regional Industry Research
7.MENA METHADONE MARKET, BY MODE OF ADMINISTRATION Market 2023-2030 ($M)
7.1 ORAL MEDICINE Market 2023-2030 ($M) - Regional Industry Research
7.1.1 Tablets Market 2023-2030 ($M)
7.1.2 Liquid Market 2023-2030 ($M)
7.2 INJECTIONS Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Methadone Market Revenue, 2023-2030 ($M)2.Canada Methadone Market Revenue, 2023-2030 ($M)
3.Mexico Methadone Market Revenue, 2023-2030 ($M)
4.Brazil Methadone Market Revenue, 2023-2030 ($M)
5.Argentina Methadone Market Revenue, 2023-2030 ($M)
6.Peru Methadone Market Revenue, 2023-2030 ($M)
7.Colombia Methadone Market Revenue, 2023-2030 ($M)
8.Chile Methadone Market Revenue, 2023-2030 ($M)
9.Rest of South America Methadone Market Revenue, 2023-2030 ($M)
10.UK Methadone Market Revenue, 2023-2030 ($M)
11.Germany Methadone Market Revenue, 2023-2030 ($M)
12.France Methadone Market Revenue, 2023-2030 ($M)
13.Italy Methadone Market Revenue, 2023-2030 ($M)
14.Spain Methadone Market Revenue, 2023-2030 ($M)
15.Rest of Europe Methadone Market Revenue, 2023-2030 ($M)
16.China Methadone Market Revenue, 2023-2030 ($M)
17.India Methadone Market Revenue, 2023-2030 ($M)
18.Japan Methadone Market Revenue, 2023-2030 ($M)
19.South Korea Methadone Market Revenue, 2023-2030 ($M)
20.South Africa Methadone Market Revenue, 2023-2030 ($M)
21.North America Methadone By Application
22.South America Methadone By Application
23.Europe Methadone By Application
24.APAC Methadone By Application
25.MENA Methadone By Application
26.QINGHAI PHARM, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.ROXANE, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.CENTRALPHARM, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.MALLINCKRODT, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.MACFARLAN SMITH, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.VISTAPHARM, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.DISKETS, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.METHADOES, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.AUROLIFE PHARMA LLC, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.DOLOPHINE, Sales /Revenue, 2015-2018 ($Mn/$Bn)